Research has established that elevated TGFβ levels in the tumor microenvironment represent one of the determining factors that inhibit T-cell infiltration into tumors and contribute to poor response to PD-1/PD-L1 inhibitor blockade [87,88]. This evidence concerns the gene CD274 and neoplasm.